Abbott LaboratoriesABTNYSE

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 89% recommend buying.

Consensus Rating

Buy

19 analysts·Moderate coverage

89%

Rating Distribution

Strong Buy

00%

Buy

1789%

Hold

211%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 19% higher.

Bear Case

$144.00

+14%

Consensus

$150.25

+19%

Bull Case

$169.00

+34%

Price Range19 analysts

Low

Consensus

High

$144.00

$169.00

Current Target

Current Price

$125.92

Upside to Target

$24.33

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$5.67(18 analysts)

P/E16x

Current: 15.8x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+7.45%

EPS+10.49%

FY2028

Rev+7.07%

EPS+10.78%

FY2029

Rev+6.52%

EPS+8.55%

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+3.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 9, 2026Bernstein

Abbott price target raised to $154 from $150 at Bernstein

Target:$154.00

+22.0%from $126.18

Jan 9, 2026Goldman Sachs

Abbott price target lowered to $152 from $157 at Goldman Sachs

Target:$152.00

+20.5%from $126.18

Jan 5, 2026Evercore ISI

Abbott price target raised to $144 from $142 at Evercore ISI

Target:$144.00

+16.2%from $123.97

Jan 5, 2026Barclays

Abbott price target raised to $169 from $162 at Barclays

Target:$169.00

+36.1%from $124.19

Dec 22, 2025BTIG

BTIG Reiterates Buy Rating on Abbott Labs (ABT)

Target:$145.00

+14.9%from $126.24

Nov 21, 2025Tigress Financial

Benchmark Reiterates Buy Rating on Abbott Labs (ABT) Following Deal to Acquire Exact Sciences (EXAS)

Target:$145.00

+13.2%from $128.13

Oct 17, 2025Barclays

Abbott price target raised to $162 from $159 at Barclays

Target:$162.00

+26.9%from $127.63

Oct 16, 2025Wells Fargo

Abbott price target raised to $146 from $142 at Wells Fargo

Target:$146.00

+12.8%from $129.45

Oct 1, 2025Goldman Sachs

Abbott added to US Conviction List at Goldman Sachs

Target:$157.00

+17.2%from $133.94

Jul 15, 2025RBC Capital

Abbott price target raised to $147 from $145 at RBC Capital

Target:$147.00

+11.8%from $131.49

Apr 15, 2025RBC Capital

Abbott price target raised to $140 from $135 at RBC Capital

Target:$140.00

+10.9%from $126.22

Jan 8, 2025Bernstein

Abbott price target lowered to $135 from $138 at Bernstein

Target:$135.00

+18.2%from $114.25

Oct 17, 2024Piper Sandler

Abbott Labs (ABT) PT Raised to $133 at Piper Sandler

Target:$133.00

+12.9%from $117.82

Oct 17, 2024Bernstein

Abbott price target raised to $138 from $133 at Bernstein

Target:$138.00

+17.1%from $117.82

Oct 16, 2024Jefferies

Abbott Labs (ABT) PT Raised to $125 at Jefferies

Target:$125.00

+6.1%from $117.82

Oct 16, 2024Evercore ISI

Abbott Labs (ABT) PT Raised to $128 at Evercore ISI

Target:$128.00

+8.6%from $117.82

Oct 16, 2024BTIG

Abbott Labs (ABT) PT Raised to $139 at BTIG

Target:$139.00

+18.0%from $117.82

Oct 8, 2024Susquehanna

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Target:$120.00

+5.0%from $114.30

Oct 8, 2024Oppenheimer

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Target:$130.00

+13.7%from $114.30

Oct 8, 2024RBC Capital

Abbott price target raised to $130 from $125 at RBC Capital

Target:$130.00

+14.7%from $113.36

Sep 19, 2024RBC Capital

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Target:$345.00

+533.1%from $54.49

Sep 19, 2024Roth Capital

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Target:$50.00

-8.2%from $54.49

Sep 19, 2024Piper Sandler

Abbott initiated with an Overweight at Piper Sandler

Target:$131.00

+14.0%from $114.88

Aug 27, 2024Jefferies

Jefferies Reiterates Hold Rating on Abbott Labs (ABT)

Target:$120.00

+6.9%from $112.22

Aug 22, 2024Citigroup

Abbott price target raised to $127 from $119 at Citi

Target:$127.00

+14.0%from $111.39

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance